Cited by 51Psychedelics and Drug StudiesTreatment of Major DepressionCancer survivorship and care

Assessment of Psilocybin Therapy for Patients With Cancer and Major Depression Disorder

Open access
Agrawal, Manish, Emanuel, Ezekiel, Richards, Brian, Richards, William, Roddy, Kim, Thambi, Paul·2023·JAMA Oncology

Abstract

This nonrandomized controlled trial used a 1-to-1 therapist-to-patient ratio to administer psilocybin to groups of patients with cancer who were diagnosed with major depression disorder to create a scalable, rapidly effective depression treatment.

Integrity signals

Registry

Crossref · 10.1001/jamaoncol.2023.0351

Cites

7 of 8 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Cites

Flagged first, then by citations

Research works printed but not linked: 16

  1. Tsapekos, D., Strawbridge, R., Cleare, A., Disorders, A. Y.-B. & 2016, undefined. Measuring depression in clinical trials: a systematic review of the HAM-D original scale versus the embedded subscales as efficacy measures: P-338.
  2. McCormack, H. M., Horne, D. J. d. L. & Sheather, S. Clinical applications of visual analogue scales: A critical review. Psychol. Med. 18, 1007-1019 (1988).
  3. Hofmann, A. Isolement de la Psilocybine à partir du Stropharia cubensis Earle et d'autres espèces de champignons hallucinogènes mexicains appartenant au genre Psilocybe. Comptes rendus Académie des sciences vol. 4 557-561 (1958).
  4. Passie, T. A History of Use of Psilocybin in Psychotherapy. Sacred Mushroom of Visions: Teonanacatl: a sourcebook on the psilocybin mushroom (Park Street Press, 2005).
  5. Coyne, J. C., Lepore, S. J. & Palmer, S. C. Efficacy of psychosocial interventions in cancer care: Evidence is weaker than it first looks. in Annals of Behavioral Medicine vol. 32 104-110 (2006).
  6. Coyne, J. C. & Lepore, S. J. Rebuttal: The black swan fallacy in evaluating psychological interventions for distress in cancer patients. in Annals of Behavioral Medicine vol. 32 115-118 (2006).
  7. Lepore, S. J. & Coyne, J. C. Psychological interventions for distress in cancer patients: A review of reviews. in Annals of Behavioral Medicine vol. 32 85-92 (2006).
  8. Manne, S. L. & Andrykowski, M. A. Are psychological interventions effective and accepted by cancer patients? II. Using empirically supported therapy guidelines to decide. in Annals of Behavioral Medicine vol. 32 98-103 (2006).
  9. Andrykowski, M. A. & Manne, S. L. Are psychological interventions effective and accepted by cancer patients? I. Standards and levels of evidence. in Annals of Behavioral Medicine vol. 32 93-97 (2006).
  10. Manne, S. L. & Andrykowski, M. A. Seeing the forest for the trees: A rebuttal. in Annals of Behavioral Medicine vol. 32 111-114 (2006).
  11. Lan Ly, K., Chidgey, J., Addington-Hall, J. & Hotopf, M. Depression in palliative care: A systematic review: Part 2. Treatment. Palliat. Med. 16, 279-284 (2002).
  12. Richards, W., Grof, S., Goodman, L. & Kurland, A. LSD-assisted psychotherapy and the human encounter with death. J. Transpers. Psychol. Vol. 4(2) 4, 121-150 (1972).
  13. Emotion Recognition Task (ERT) | Cambridge Cognition. https://www.cambridgecognition.com/cantab/cognitive-tests/emotion-and- social/emotion-recognition-task-ert/.
  14. Spatial Working Memory (SWM) | Cambridge Cognition. https://www.cambridgecognition.com/cantab/cognitive-tests/memory/spatial-working- memory-swm/.
  15. Carhart-Harris, R. L. et al. Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. Proc. Natl. Acad. Sci. 109, 2138-2143 (2012).
  16. Studerus, E., Gamma, A. & Vollenweider, F. X. Psychometric Evaluation of the Altered States of Consciousness Rating Scale (OAV). PLoS One 5, e12412 (2010).

Cited by

Sorted by citations

Authors
Agrawal, M., Emanuel, E., Richards, B., Richards, W., Roddy, K., & Thambi, P.
Affiliations
  • Sunstone Therapies, Rockville, Maryland
  • University of Pennsylvania (US)
  • Maryland Oncology Hematology (US)
Corresponding author
Agrawal, Manish
Venue
JAMA Oncology
Published
2023-06-01
Volume
9
Issue
6
Pages
864
ISSN
2374-2437 (ISSN-L)
OpenAlex
W4365444032
Cited by
51
References
6
Citations by year
2026: 12 · 2025: 19 · 2024: 12 · 2023: 7 · 2022: 1
FWCI
14.53
Type
journal article
Language
en
Open access
Locations
  • JAMA Oncology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
Keywords
psilocybin, major depressive disorder, cancer patients, psychedelic therapy, depression treatment, group therapy
MeSH terms
Depression, Major Depressive Disorder, Humans, Neoplasms, Patients, Psilocybin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review